Abstract
Optically active N-acyl-5,5-dimethyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano[3,4-b][1,4]oxazine-9-carbonitriles 2–22 were synthesized as rigid analogues of cromakalim. The (4aR,10bR)-N-benzoyl derivative (−)-11 was identified as a bladder-selective KCO (IC50, bladder=8.2μM, IC50, portal vein=34.5μM). Among the analogues of 11 with substitution on the benzoyl moiety, the 3-methyl analogue (−)-14 showed highly potent and selective activity at portal vein (IC50, bladder=279μM, IC50, portal vein=0.54μM). The 4-bromo analogue (−)-19 (IC50, bladder=2.0μM, IC50, portal vein=8.1μM) and the 4-hydroxy analogue (−)-21 (IC50, bladder=3.8μM, IC50, portal vein=75μM) showed enhanced activity at the bladder, while maintaining unprecedented bladder selectivity in vitro. The N-benzenesulfonyl analogue (−)-22, a bioisoster of (−)-11, showed similar activity at the bladder with enhanced selectivity (IC50, bladder=11.6μM, IC50, portal vein=120μM).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
